Smouldering malignant melanoma and metastatic dormancy: an update and review
- PMID: 22110487
- PMCID: PMC3216350
- DOI: 10.1155/2012/461278
Smouldering malignant melanoma and metastatic dormancy: an update and review
Abstract
The fund of knowledge regarding the versatility of presentation of MM metastases is still quite incomplete. The recent literature pertaining to the current understanding of the mechanisms underlying two special features of MM metastasis is reviewed. On the one hand, a long disease-free interval (MM dormancy) may occur before the surge of overt metastases. On the other hand, the so-called MM smouldering phenomenon refers to the condition where regional metastases wax and wane for long periods of time on restricted skin regions. It is important to emphasize that local micrometastases often predict sentinel lymph node involvement but may not reflect progression of the primary MM to full-blown visceral metastatic competence. It is likely that a combination of factors impacts the versatile MM metastasic progression. Among the main factors, one has to mention the phenotypic heterogeneity and variability in the phenotype of MM cells, the presence of MM stem cells and MM cells engaged in an amplification proliferation pool, as well as the host immune response, and possibly the induction of a particular stromal structure and vascularity.
Figures
Similar articles
-
Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.Oncol Rev. 2014 Sep 23;8(2):252. doi: 10.4081/oncol.2014.252. eCollection 2014 Sep 23. Oncol Rev. 2014. PMID: 25992239 Free PMC article. Review.
-
The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?Oncologist. 1998;3(5):VI-VII. Oncologist. 1998. PMID: 10388128
-
Assessment of proliferation markers in metastatic melanoma in sentinel lymph nodes.J Clin Pathol. 2011 Dec;64(12):1108-11. doi: 10.1136/jclinpath-2011-200242. Epub 2011 Sep 6. J Clin Pathol. 2011. PMID: 21896579
-
Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.Br J Dermatol. 2002 Jul;147(1):62-70. doi: 10.1046/j.1365-2133.2002.04867.x. Br J Dermatol. 2002. PMID: 12100186
-
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.Dan Med J. 2012 Jul;59(7):B4475. Dan Med J. 2012. PMID: 22759850 Review.
Cited by
-
Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.Oncol Rev. 2014 Sep 23;8(2):252. doi: 10.4081/oncol.2014.252. eCollection 2014 Sep 23. Oncol Rev. 2014. PMID: 25992239 Free PMC article. Review.
-
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma.Cancers (Basel). 2021 Dec 27;14(1):110. doi: 10.3390/cancers14010110. Cancers (Basel). 2021. PMID: 35008274 Free PMC article.
-
Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.ISRN Dermatol. 2012;2012:828146. doi: 10.5402/2012/828146. Epub 2012 Jan 11. ISRN Dermatol. 2012. PMID: 22363864 Free PMC article.
References
-
- Elder DE, Van Belle P, Elenitsas R, Halpern A, Guerry D. Neoplastic progression and prognosis in melanoma. Seminars in Cutaneous Medicine and Surgery. 1996;15(4):336–348. - PubMed
-
- Quatresooz P, Piérard-Franchimont C, Paquet P, Piérard GE. Angiogenic fast-growing melanomas and their micrometastases. European Journal of Dermatology. 2010;20(3):302–307. - PubMed
-
- Attis MG, Vollmer RT. Mitotic rate in melanoma: a reexamination. American Journal of Clinical Pathology. 2007;127(3):380–384. - PubMed
LinkOut - more resources
Full Text Sources